| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |